期刊文献+

局限性巨淋巴结增生的临床特征及治疗 被引量:10

Clinical characteristics and surgical treatment for localized Castleman's disease
原文传递
导出
摘要 目的探讨局限性巨淋巴结增生的临床特征及治疗方法,以提高对该病的诊治水平。方法回顾性分析20例经手术切除的局限性巨淋巴结增生患者的临床、病理、影像学特点,并经随访评价手术治疗效果。结果患者多为中青年(平均年龄37.7岁)。肿瘤位于腹膜后9例,纵隔7例,盆腔1例,颈部1例,上臂1例,腋窝1例。5例行腔镜手术,15例行开放手术。术后病理诊断为透明血管型17例,浆细胞型1例,混合型2例。16例患者随访12~165个月,其中15例未见肿瘤复发,1例复发。结论局限性巨淋巴结增生以透明血管型为主,临床症状不典型,实验室检查大多正常,影像学检查对诊断有一定帮助,确诊需要靠病理诊断,手术彻底切除疗效好。 Objective To investigate the clinical characteristics and treatment of localized Castleman's disease (CD), and review the literatures to improve the diagnosis and management of this disease. Methods The clinical symptoms, histopathology, CT, MRI findings and results of surgery in 20 patients with localized CD were evaluated retrospectively. Results The average age of the patients was 37.7 years. The lesions were located in the retroperitoneal space (9 cases), mediastinum (7 cases), pelvic cavity (1 case), neck (1 case), upper arm (1 case), and axillary (1 case). All patients underwent surgical resection, including 9 cases for retroperitoneal resection (6 cases had open operation and 3 cases laparoscopic resection) and 7 cases for mediastinal resection (open operation in 5 cases and thoracoscopic resection in 2 cases). The Castleman's disease was confirmed by histopathology. There were hyaline vascular type of CD in 17 cases, plasma cell type of CD in 1 case, and mixed cellularity type of CD in 2 cases. The duration of follow-up ranged from 12 to 165 months for 16 cases. Among them 15 patients were alive without recurrence, and 1 case had recurrence in the primary site at 47 months after the operation. Conclusions Patients with Castleman's disease have no typical clinical symptoms and have normal laboratory results. The majority of patients are of hyaline vascular type of the disease. Imaging examination is helpful to diagnosis, and the final diagnosis depends on pathologic examination. Complete surgical resection of the tumor is the best treatment for localized Castleman's disease.
出处 《中华肿瘤杂志》 CAS CSCD 北大核心 2012年第1期61-64,共4页 Chinese Journal of Oncology
关键词 巨淋巴结增生 临床特征 诊断 治疗 Giant lymph node hyperplasia Clinical characteristics Diagnosis Therapy
  • 相关文献

参考文献16

  • 1Casper C. The aetiology and management of Castleman disease at 50 years: translating pathophysiology to patient care. Br J Haematol, 2005, 129:3-17.
  • 2Dham A, Peterson BA. Castleman Disease. Curr Opin Hematol, 2007, 14:354-359.
  • 3Matsumura K, Nakasu S, Tanaka T, et al. Intracranial localized Castleman's disease: case report. Neurol Med Chir (Tokyo), 2005, 45:59-65.
  • 4McClain KL, Natkunam Y, Swerdlow SH. Atypical cellular disorders. Hematology (Am Soc Hematol Educ Program), 2004, 1:283-296.
  • 5Kojima M, Nakamura N, Tsukamoto N, et al. Clinical implications of idiopathic multicentric Castleman disease among Japanese: a report of 28 cases. Int J Surg Pathol, 2008, 16:391-398.
  • 6Zhu X, Zhang B. Paraneoplastic pemphigus. J Dermatol, 2007, 34:503-511.
  • 7Vasef M, Katzin WE, Mendelsohn G, et al. Report of a case of localized Castleman' s disease with progression to malignant lymphoma. Am J Clin Pathol, 1992, 98:633-636.
  • 8Gerald W, Kostianovsky M, Rosai J. Development of vascular neoplasia in Castleman's disease. Report of seven cases. Am J Surg Pathol, 1990, 14:603-614.
  • 9Nguyen DT. Castleman disease//Weiss LM. Lymph nodes. New York: Cambridge University Press, 2008:25-32.
  • 10Zhou LP, Zhang B, Peng WJ, et al. Imaging findings of Castleman disease of the abdomen and pelvis. Abdom Imaging, 2008, 33:482- 488.

同被引文献82

  • 1Hisaaki Miyoshi,Shima Mimura,Takako Nomura,Joji Tani,Asahiro Morishita,Hideki Kobara,Hirohito Mori,Hirohito Yoneyama,Akihiro Deguchi,Takashi Himoto,Naoki Yamamoto,Keiichi Okano,Yasuyuki Suzuki,Tsutomu Masaki.A rare case of hyaline-type Castleman disease in the liver[J].World Journal of Hepatology,2013,5(7):404-408. 被引量:14
  • 2章正华,刘瑜,万楚成,夏云金.Castleman病诊断与治疗[J].实用医学杂志,2005,21(15):1665-1667. 被引量:5
  • 3周良平,张蓓,王佩华,关玉宝,彭卫军,杨文涛,周康荣.腹、盆部巨大淋巴结增生的影像学表现[J].中华放射学杂志,2006,40(5):522-526. 被引量:51
  • 4贾宗师,周逢强,高峰,丁宝忠,徐宏.腹膜后Castleman病二例并文献复习[J].中华全科医师杂志,2006,5(6):363-364. 被引量:3
  • 5周建军,程伟中,曾维新,曾蒙苏,王建华,周康荣.腹部肾上腺外嗜铬细胞瘤:双期增强的影像学诊断价值[J].放射学实践,2007,22(10):1058-1062. 被引量:25
  • 6VAN RHEE F,STONE K, SZMANIAS, et al. Castleman dis-ease in the 21st century : an update on diagnosis,assessment,and therapy [J]. Clin Adv Hematol Oncol, 2010,8(7): 486-498.
  • 7TALAT N, SCHULTE KM. Castleman’s disease:systematic a-nalysis of 416 patients from the literature [J]. Oncologist,2011, 16(9):1316-1324.
  • 8XU D, LU J,DONG Y, et al. Renal involvement in a largecohort of Chinese patients with Castleman disease[j]. NephrolDial Transplant, 2012,Suppl 3 :iii119-iii125.
  • 9KIM MH, HWANG S, CHOI YB, et al. Castleman disease ofthe abdomen—single-center experience of 13 surgically treatedpatients over 11 years[J]. Hepatogastroenterology, 2010,57.102/103):1060-1063.
  • 10RAMASAMY K, GANDHI S, TENANT-FLOWERS M, et al.Rituximab and thalidomide combination therapy for Castlemandisease[J]. Br J Haematol, 2012, 158(3):421-423.

引证文献10

二级引证文献62

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部